List of excipients
Methyl-4-hydroxybenzoate
Sodium chloride
Sodium carbonate
Water for Injections
Major incompatibilities
The concurrent intravenous use of potentiated sulphonamides with alpha-2 agonists has been reported to cause cardiac arrhythmias which may be fatal. Whilst no such effects have been reported with xylazine, it is recommended that intravenous administration of Trimethoprim/Sulphonamide containing products should not be undertaken when horses have been sedated with Rompun.
Shelf life
Shelf life of product: 3 years
Shelf life after reconstitution: Not applicable
Shelf after opening package: 28 days
Special precautions for storage
Do not store above 25oC
Following withdrawal of the first dose use the product within 28 days.
Discard unused material.
Nature and composition of immediate packaging
A clear, colourless, sterile, aqueous solution of Xylazine hydrochloride (2.332% w/v) for parenteral administration in cattle, horses, dogs and cats.
25ml clear glass flint type II glass vial with a siliconised chlorobutyl rubber bung and secured with an aluminium and polypropylene overseal.
Special precautions for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products, if appropriate
Any unused product or waste material should be disposed of in accordance with national requirements.